Skip to content
OpenCapital
Get started

Blend Labs BLND Cash, Cash Equivalents, Restricted Cash And Short Term Investments, Amortized Cost

Other financials

Income statement

See full
Revenue$30.8M+14.9%
Gross profit$23.4M+23.0%
Operating income-$5.1M+36.6%
Net income-$8.0M+15.4%
EPS (diluted)-$0.05+16.7%

Balance sheet

See full
Cash & equivalents$39.4M-35.7%
Total debt$1.4M-20.8%
Total equity-$55.9M-226%
Total assets$161.3M-14.0%

Cash flow

See full
Operating cash flow$7.4M-63.5%
CapEx$1.1M-74.1%
Free cash flow$6.2M-60.5%

Valuation

See full
Market cap$392.23M-52.3%
Enterprise value$354.22M-53.5%
P/S3.1×-3.8×

Profitability

See full
Gross margin74.9%+2.3pp
Operating margin-14.7%-5.0pp
Net margin-4.2%-1.9pp
FCF margin-7.6%-8.9pp

Returns & leverage

See full
Return on equity-251.8%+881pp
Debt / equity36.8×+35.5×
Current ratio1.8×-0.6×

Where this comes from

Reported directly by Blend Labs in its filing.

Tagged under the XBRL concept blnd:CashCashEquivalentsRestrictedCashAndShortTermInvestmentsAmortizedCost.

The official record: Blend Labs’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Blend Labs's cash, cash equivalents, restricted cash and short term investments, amortized cost.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Blend Labs's cash, cash equivalents, restricted cash and short term investments, amortized cost?
Blend Labs (BLND) reported cash, cash equivalents, restricted cash and short term investments, amortized cost of $36.81M in Q1 2026.
How has Blend Labs's cash, cash equivalents, restricted cash and short term investments, amortized cost changed year-over-year?
Blend Labs's cash, cash equivalents, restricted cash and short term investments, amortized cost decreased by 58.4% year-over-year, from $88.38M to $36.81M.
What is the long-term trend for Blend Labs's cash, cash equivalents, restricted cash and short term investments, amortized cost?
Over 2 years (2023 to 2025), Blend Labs's cash, cash equivalents, restricted cash and short term investments, amortized cost has grown at a -35.4% compound annual growth rate (CAGR), from $134.89M to $56.23M.